TABLE 1.
Group | n | CC | TC | TT | C | T |
---|---|---|---|---|---|---|
Patients | 350 | 148 (42.3) | 138 (39.4) | 64 (18.3) | 434 (62.0) | 266 (38.0) |
Controls | 300 | 139 (46.3) | 136 (45.3) | 25 (8.3) | 414 (69.0) | 186 (31.0) |
χ2 | 13.621 | 6.980 | ||||
p | 0.001 | 0.008 |
Group | n | CC | TC | TT | C | T |
---|---|---|---|---|---|---|
Patients | 350 | 148 (42.3) | 138 (39.4) | 64 (18.3) | 434 (62.0) | 266 (38.0) |
Controls | 300 | 139 (46.3) | 136 (45.3) | 25 (8.3) | 414 (69.0) | 186 (31.0) |
χ2 | 13.621 | 6.980 | ||||
p | 0.001 | 0.008 |